Review of basal-plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus.

Raccah, D; Huet, D; Dib, A; Joseph, F; Landers, B; Escalada, J; Schmitt, H

Raccah, D; Huet, D; Dib, A; Joseph, F; Landers, B; Escalada, J; Schmitt, H.

Affiliation

Raccah D; Department of Diabetes, Sainte Marguerite Hospital, Marseille.
Huet D; Department of Diabetes, Saint-Joseph Hospital, Paris.
Dib A; Eli Lilly France, Neuilly sur Seine, France.
Joseph F; Countess of Chester Hospital, Chester, UK.
Landers B; Diabetes Schwerpunktpraxis, Mayen, Germany.
Escalada J; University Hospital of Navarra, Pamplona, Spain.
Schmitt H; Eli Lilly Benelux, Brussels, Belgium.

Diabet Med ; 34(9): 1193-1204, 2017 09.

Article in En | MEDLINE | ID: mdl-28574177

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Hypoglycemic Agents / Insulin Type of study: Clinical_trials Limits: Humans Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2017 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google